Monotherapy for rheumatoid arthritis treatment?

Y Yazici¹

Affiliations

Comment

Y Yazici. Clin Exp Rheumatol. 2014 Nov-Dec.

. 2014 Nov-Dec;32(6 Suppl 87):S-4.

Epub 2014 Mar 17.

Y Yazici¹

No abstract available

Comment on

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial.
Gabay C, Emery P, van Vollenhoven R, Dikranian A, Alten R, Pavelka K, Klearman M, Musselman D, Agarwal S, Green J, Kavanaugh A; ADACTA Study Investigators. Gabay C, et al. Lancet. 2013 May 4;381(9877):1541-50. doi: 10.1016/S0140-6736(13)60250-0. Epub 2013 Mar 18. Lancet. 2013. PMID: 23515142 Clinical Trial.
Tocilizumab versus adalimumab for rheumatoid arthritis.
De Vita S. De Vita S. Lancet. 2013 May 4;381(9877):1515-7. doi: 10.1016/S0140-6736(13)60634-0. Lancet. 2013. PMID: 23642688 No abstract available.